P

Pulmatrix

PULM

2.37000
USD
0.19
(8.72%)
مغلق
حجم التداول
41
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
7,304,570
أصول ذات صلة
ABT
4.220
(3.98%)
110.150 USD
A
ANIK
-1.090
(-4.00%)
26.150 USD
A
AR
-0.240
(-0.83%)
28.770 USD
BDX
-4.995
(-2.07%)
236.055 USD
H
HSTO
0.16000
(31.99%)
0.66010 USD
I
ITRI
4.420
(4.27%)
107.870 USD
L
LIVN
-1.130
(-2.29%)
48.270 USD
N
NVTA
0
(0%)
0.000000 USD
P
PBH
-0.360
(-0.51%)
70.520 USD
الأخبار المقالات

العنوان: Pulmatrix

القطاع: Healthcare
الصناعة: Biotechnology
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmetmedical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.